Increased Ca


Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
07 07 2023
Historique:
medline: 10 7 2023
pubmed: 16 6 2023
entrez: 16 6 2023
Statut: ppublish

Résumé

A loss-of-function cardiac ryanodine receptor (RyR2) mutation, I4855M We generated a mouse model expressing the CRDS-LVNC-associated RyR2-I4855M As in humans, RyR2-I4855M The RyR2-I4855M

Sections du résumé

BACKGROUND
A loss-of-function cardiac ryanodine receptor (RyR2) mutation, I4855M
METHODS
We generated a mouse model expressing the CRDS-LVNC-associated RyR2-I4855M
RESULTS
As in humans, RyR2-I4855M
CONCLUSIONS
The RyR2-I4855M

Identifiants

pubmed: 37325910
doi: 10.1161/CIRCRESAHA.123.322504
doi:

Substances chimiques

Calcium SY7Q814VUP
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Ryanodine Receptor Calcium Release Channel 0
ryanodine receptor 2. mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-192

Subventions

Organisme : CIHR
ID : PJT-155940
Pays : Canada

Commentaires et corrections

Type : CommentIn

Auteurs

Mingke Ni (M)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Yanhui Li (Y)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Jinhong Wei (J)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).
School of Medicine, Northwest University, Xi 'an, China (J.W.).

Zhenpeng Song (Z)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Hui Wang (H)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Jinjing Yao (J)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Yong-Xiang Chen (YX)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Darrell Belke (D)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

John Paul Estillore (JP)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Ruiwu Wang (R)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Alexander Vallmitjana (A)

Department of Automatic Control, Universitat Politècnica de Catalunya, Barcelona, Spain (A.V., R.B.).

Raul Benitez (R)

Department of Automatic Control, Universitat Politècnica de Catalunya, Barcelona, Spain (A.V., R.B.).
Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain (R.B.).

Leif Hove-Madsen (L)

Biomedical Research Institute Barcelona IIBB-CSIC, IIB Sant Pau and CIBERCV, Hospital de Sant Pau, Barcelona, Spain (L.H.-M.).

Wei Feng (W)

Department of Medicine, School of Medicine, University of California, San Diego, La Jolla (W.F., J.C.).

Ju Chen (J)

Department of Medicine, School of Medicine, University of California, San Diego, La Jolla (W.F., J.C.).

Thomas M Roston (TM)

Division of Pediatric Cardiology, Department of Pediatrics (T.M.R., S.S.), University of British Columbia, Vancouver, Canada.

Shubhayan Sanatani (S)

Division of Pediatric Cardiology, Department of Pediatrics (T.M.R., S.S.), University of British Columbia, Vancouver, Canada.

Anna Lehman (A)

Department of Medical Genetics (A.L.), University of British Columbia, Vancouver, Canada.

S R Wayne Chen (SRW)

Department of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (M.N., Y.L., J.W., Z.S., H.W., J.Y., Y.-X.C., D.B., J.P.E., R.W., S.R.W.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH